BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shiotani A, Sakakibara T, Yamanaka Y, Imamura H, Tarumi K, Manabe N, Kamada T, Kusunoki H, Hata J, Haruma K. Upper gastrointestinal ulcer in Japanese patients taking low-dose aspirin. J Gastroenterol. 2009;44:126-131. [PMID: 19214674 DOI: 10.1007/s00535-008-2290-6] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 de Groot NL, Hagenaars MP, Smeets HM, Steyerberg EW, Siersema PD, van Oijen MGH. Primary non-variceal upper gastrointestinal bleeding in NSAID and low-dose aspirin users: development and validation of risk scores for either medication in two large Dutch cohorts. J Gastroenterol 2014;49:245-53. [DOI: 10.1007/s00535-013-0817-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
2 Can Ö, Koç G, Ocak SB, Akbay N, Ahishali E, Canbakan M, Şahin GM, Apaydin S. Gastrointestinal bleeding in patients with renal failure under hemodialysis treatment: a single-center experience. Int Urol Nephrol 2017;49:889-94. [PMID: 28124306 DOI: 10.1007/s11255-017-1517-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
3 Miwa H, Hongo M, Kusano M; The J-FAST Group. Combination of angiotensin II receptor blockers promotes proton pump inhibitor-based healing of reflux esophagitis. J Gastroenterol 2012;47:249-55. [DOI: 10.1007/s00535-011-0479-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
4 Iwamoto J, Saito Y, Honda A, Matsuzaki Y. Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy. World J Gastroenterol 2013; 19(11): 1673-1682 [PMID: 23555156 DOI: 10.3748/wjg.v19.i11.1673] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
5 Chou CY, Wang SM, Chang PH, Kuo HL, Chang CT, Liu JH, Wang IK, Yang YF, Liang CC, Huang CC. Angiotensin II receptor blocker prevents upper gastrointestinal bleeding in hypertensive patients with chronic kidney disease not on dialysis. Int J Clin Pract 2015;69:722-8. [PMID: 25651030 DOI: 10.1111/ijcp.12589] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
6 Xie Y, Zhu L, Wang Z, Zhan X, Peng F, Feng X, Zhou Q, Wu X, Wang X, Su N, Tang X, Zhang Y, Zeng Y, Li M, Liang J, Liu L, Wen Y. ACEi/ARBs associate with lower incidence of gastrointestinal bleeding in peritoneal dialysis patients. Clin Exp Nephrol 2021. [PMID: 34698915 DOI: 10.1007/s10157-021-02150-4] [Reference Citation Analysis]
7 Nagata N, Niikura R, Sekine K, Sakurai T, Shimbo T, Kishida Y, Tanaka S, Aoki T, Okubo H, Watanabe K, Yokoi C, Akiyama J, Yanase M, Mizokami M, Uemura N. Risk of peptic ulcer bleeding associated with Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs, low-dose aspirin, and antihypertensive drugs: a case-control study. J Gastroenterol Hepatol 2015;30:292-8. [PMID: 25339607 DOI: 10.1111/jgh.12805] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
8 Tran-duy A, Vanmolkot FH, Joore MA, Hoes AW, Stehouwer CDA. Should patients prescribed long-term low-dose aspirin receive proton pump inhibitors? A systematic review and meta-analysis. Int J Clin Pract 2015;69:1088-111. [DOI: 10.1111/ijcp.12634] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
9 Shiotani A, Murao T, Sakakibara T, Tarumi K, Manabe N, Kamada T, Kusunoki H, Haruma K. Association of SLCO1B1 1b with peptic ulcer amongst Japanese patients taking low-dose aspirin. Dig Liver Dis. 2012;44:201-205. [PMID: 22088425 DOI: 10.1016/j.dld.2011.10.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
10 Shiotani A, Sakakibara T, Yamanaka Y, Nishi R, Imamura H, Fujita M, Tarumi K, Kamada T, Hata J, Haruma K. The preventive factors for aspirin-induced peptic ulcer: aspirin ulcer and corpus atrophy. J Gastroenterol. 2009;44:717-725. [PMID: 19448967 DOI: 10.1007/s00535-009-0068-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
11 Ito Y, Sasaki M, Noguchi S, Yamaguchi S, Okaniwa N, Tanabe A, Noda H, Yanamoto K, Tamura Y, Kondo Y, Masui R, Izawa S, Iida A, Mizuno M, Ogasawara N, Funaki Y, Kasugai K. Effect of aspirin cessation before endoscopy in Japanese patients with low-dose-aspirin-associated gastroduodenal mucosal injury. United European Gastroenterol J. 2013;1:259-264. [PMID: 24917970 DOI: 10.1177/2050640613491254] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
12 Tatsuta T, Chinda D, Mikami T, Suto S, Akitaya K, Igarashi S, Hasui K, Kikuchi H, Hiraga H, Sawaya M, Sakuraba H, Shimoyama T, Fukuda S. Esophageal achalasia with mucosal damage due to enteric-coated aspirin. Clin J Gastroenterol 2021. [PMID: 34347244 DOI: 10.1007/s12328-021-01494-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Shiotani A, Murao T, Fujita Y, Fujimura Y, Sakakibara T, Nishio K, Haruma K. Single nucleotide polymorphism markers for low-dose aspirin-associated peptic ulcer and ulcer bleeding. J Gastroenterol Hepatol 2014;29 Suppl 4:47-52. [PMID: 25521733 DOI: 10.1111/jgh.12770] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
14 Zhou H, Lv NH. Risk factors for peptic ulcer bleeding. Shijie Huaren Xiaohua Zazhi 2010; 18(33): 3544-3547 [DOI: 10.11569/wcjd.v18.i33.3544] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
15 Origasa H, Goto S, Shimada K, Uchiyama S, Okada Y, Sugano K, Hiraishi H, Uemura N, Ikeda Y; MAGIC Investigators. Prospective cohort study of gastrointestinal complications and vascular diseases in patients taking aspirin: rationale and design of the MAGIC Study. Cardiovasc Drugs Ther. 2011;25:551-560. [PMID: 21842134 DOI: 10.1007/s10557-011-6328-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
16 Brzozowski T. Role of renin-angiotensin system and metabolites of angiotensin in the mechanism of gastric mucosal protection. Curr Opin Pharmacol 2014;19:90-8. [PMID: 25238456 DOI: 10.1016/j.coph.2014.08.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
17 Sogabe M, Okahisa T, Nakasono M, Fujino Y, Mitsui Y, Takaoka Y, Kimura T, Okamoto K, Muguruma N, Takayama T. Investigation of Gastroduodenal Mucosal Injury in Japanese Asymptomatic Antiplatelet Drug Users. Medicine (Baltimore) 2015;94:e1047. [PMID: 26131815 DOI: 10.1097/MD.0000000000001047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Handa Y, Fukushima S, Yo S, Osawa M, Murao T, Handa O, Matsumoto H, Umegaki E, Sakakibara T, Shiotani A. A novel gene associated with small bowel bleeding in patients taking low-dose aspirin. Dig Liver Dis 2021;53:841-5. [PMID: 34059446 DOI: 10.1016/j.dld.2021.04.038] [Reference Citation Analysis]
19 Uemura N, Sugano K, Hiraishi H, Shimada K, Goto S, Uchiyama S, Okada Y, Origasa H, Ikeda Y; MAGIC Study Group. Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study. J Gastroenterol. 2014;49:814-824. [PMID: 23754512 DOI: 10.1007/s00535-013-0839-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
20 Tang CL, Ye F, Liu W, Pan XL, Qian J, Zhang GX. Eradication of Helicobacter pylori infection reduces the incidence of peptic ulcer disease in patients using nonsteroidal anti-inflammatory drugs: a meta-analysis. Helicobacter. 2012;17:286-296. [PMID: 22759329 DOI: 10.1111/j.1523-5378.2012.00942.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
21 Cosma A, Bănescu C, Mocan S, Balla B, Negovan A. Congestive Heart Failure and Upper Digestive Endoscopic Lesions. Acta Medica Marisiensis 2019;65:19-24. [DOI: 10.2478/amma-2019-0001] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
22 Sarri GL, Grigg SE, Yeomans ND. Helicobacter pylori and low-dose aspirin ulcer risk: A meta-analysis: H. pylori and low-dose aspirin ulcers. Journal of Gastroenterology and Hepatology 2019;34:517-25. [DOI: 10.1111/jgh.14539] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
23 Negovan A, Iancu M, Moldovan V, Voidazan S, Bataga S, Pantea M, Sarkany K, Tatar C, Mocan S, Banescu C. Clinical Risk Factors for Gastroduodenal Ulcer in Romanian Low-Dose Aspirin Consumers. Gastroenterol Res Pract 2016;2016:7230626. [PMID: 27579036 DOI: 10.1155/2016/7230626] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
24 Amano Y, Uno G, Yuki T, Okada M, Tada Y, Fukuba N, Ishimura N, Ishihara S, Kinoshita Y. Interobserver variation in the endoscopic diagnosis of gastroduodenal ulcer scars: implications for clinical management of NSAIDs users. BMC Res Notes 2011;4:409. [PMID: 21996289 DOI: 10.1186/1756-0500-4-409] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
25 Iijima K, Ara N, Abe Y, Koike T, Iwabuchi T, Shinkai H, Uno K, Endo H, Asano N, Shimosegawa T. Biphasic effects of H. pylori infection on low-dose aspirin-induced gastropathy depending on the gastric acid secretion level. J Gastroenterol. 2012;47:1290-1297. [PMID: 22549566 DOI: 10.1007/s00535-012-0598-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
26 Shiotani A, Manabe N, Kamada T, Fujimura Y, Sakakibara T, Haruma K. Risk and preventive factors of low-dose aspirin-induced gastroduodenal injuries: a comprehensive review. J Gastroenterol Hepatol 2012;27 Suppl 3:8-12. [PMID: 22486865 DOI: 10.1111/j.1440-1746.2012.07071.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
27 Fukuda S, Hosaka S, Ozawa N, Akita S, Kashima T, Kimura S, Akiyama J, Mizoue T. Gastric injury caused by low-dose aspirin therapy in consecutive Japanese patients: a prospective study. Gen Thorac Cardiovasc Surg. 2012;60:275-279. [PMID: 22453536 DOI: 10.1007/s11748-011-0886-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
28 Shiotani A, Sakakibara T, Nomura M, Yamanaka Y, Nishi R, Imamura H, Tarumi K, Kamada T, Hata J, Haruma K. Aspirin-induced peptic ulcer and genetic polymorphisms. J Gastroenterol Hepatol 2010;25 Suppl 1:S31-4. [PMID: 20586862 DOI: 10.1111/j.1440-1746.2009.06212.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
29 Shiotani A, Honda K, Murao T, Ishii M, Fujita M, Matsumoto H, Tarumi K, Kamada T, Sakakibara T, Haruma K. Combination of low-dose aspirin and thienopyridine exacerbates small bowel injury. Scand J Gastroenterol 2011;46:281-6. [PMID: 21133822 DOI: 10.3109/00365521.2010.533381] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
30 Sugimoto M, Ohno T, Yamaoka Y. Expression of angiotensin II type 1 and type 2 receptor mRNAs in the gastric mucosa of Helicobacter pylori-infected Mongolian gerbils. J Gastroenterol 2011;46:1177-86. [PMID: 21750885 DOI: 10.1007/s00535-011-0433-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
31 Sugano K, Matsumoto Y, Itabashi T, Abe S, Sakaki N, Ashida K, Mizokami Y, Chiba T, Matsui S, Kanto T. Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial. J Gastroenterol. 2011;46:724-735. [PMID: 21499703 DOI: 10.1007/s00535-011-0397-7] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 3.9] [Reference Citation Analysis]
32 Shimada Y, Nagahara A, Hojo M, Asaoka D, Sasaki H, Ueyama H, Matsumoto K, Watanabe S. Upper gastrointestinal mucosal injury and symptoms in elderly low-dose aspirin users. Gastroenterol Res Pract 2015;2015:252963. [PMID: 25691897 DOI: 10.1155/2015/252963] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
33 Yamamoto T, Isono A, Mishina Y, Ebato T, Shirai T, Nakayama S, Nagasawa K, Abe K, Hattori K, Ishii T. Gastroduodenal mucosal injury in patients taking low-dose aspirin and the role of gastric mucoprotective drugs: possible effect of rebamipide. J Clin Biochem Nutr. 2010;47:27-31. [PMID: 20664727 DOI: 10.3164/jcbn.09-103] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
34 Shiotani A, Murao T, Fujita Y, Fujimura Y, Sakakibara T, Nishio K, Haruma K. Novel single nucleotide polymorphism markers for low dose aspirin-associated small bowel bleeding. PLoS One. 2013;8:e84244. [PMID: 24367646 DOI: 10.1371/journal.pone.0084244] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
35 Kawai T, Watanabe M, Yamashina A. Impact of upper gastrointestinal lesions in patients on low-dose aspirin therapy: preliminary study. J Gastroenterol Hepatol. 2010;25 Suppl 1:S23-S30. [PMID: 20586861 DOI: 10.1111/j.1440-1746.2010.06225.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
36 Yamanaka K, Miyatani H, Yoshida Y, Asabe S, Yoshida T, Nakano M, Obara S, Endo H. Hemorrhagic gastric and duodenal ulcers after the Great East Japan Earthquake Disaster. World J Gastroenterol 2013; 19(42): 7426-7432 [PMID: 24259974 DOI: 10.3748/wjg.v19.i42.7426] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
37 Negovan A, Voidăzan S, Pantea M, Moldovan V, Bataga S, Cozlea L, Mocan S, Banescu C. AGT A-20C (rs5050) gene polymorphism and ulcer occurrence in patients treated with low-dose aspirin: a case-control study / Polimorfismul AGT A-20C și ulcerele gastro-duodenale la pacienții sub tratament cu aspirină în doze antiagregante: studiu caz-control. Romanian Review of Laboratory Medicine 2015;23. [DOI: 10.1515/rrlm-2015-0017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
38 Liang CC, Muo CH, Wang IK, Chang CT, Chou CY, Liu JH, Yen TH, Huang CC, Chung CJ. Peptic ulcer disease risk in chronic kidney disease: ten-year incidence, ulcer location, and ulcerogenic effect of medications. PLoS One. 2014;9:e87952. [PMID: 24498412 DOI: 10.1371/journal.pone.0087952] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
39 Costa-moreira P, Vilas-boas F, Teixeira Fraga A, Macedo G. Particular aspects of gastroenterological disorders in chronic kidney disease and end-stage renal disease patients: a clinically focused review. Scandinavian Journal of Gastroenterology 2020;55:129-38. [DOI: 10.1080/00365521.2020.1722217] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Kakiuchi T, Kumamoto T, Koji A, Matsuo M. Low-dose aspirin-induced gastric mucosal injury after Fontan surgery in an adolescent. Clin Case Rep 2021;9:2460-4. [PMID: 33936713 DOI: 10.1002/ccr3.4070] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Shiotani A, Nishi R, Yamanaka Y, Murao T, Matsumoto H, Tarumi K, Kamada T, Sakakibara T, Haruma K. Renin-angiotensin system associated with risk of upper GI mucosal injury induced by low dose aspirin: renin angiotensin system genes' polymorphism. Dig Dis Sci. 2011;56:465-471. [PMID: 20824505 DOI: 10.1007/s10620-010-1382-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]